OM:XVIVOMedical Equipment
Xvivo Perfusion (OM:XVIVO) Stock Faces Margin Compression Despite Strong Q2 2026 Revenue Growth
Xvivo Perfusion (OM:XVIVO) has put fresh numbers on the table for Q2 2026, with revenue of SEK 239.0 million, basic EPS of SEK 0.52 and net income of SEK 16.3 million setting the tone for the latest update. The company has seen quarterly revenue move from SEK 178.3 million in Q2 2025 to SEK 238.99 million in Q2 2026, while basic EPS shifted from SEK 0.05 to SEK 0.52 and trailing twelve month EPS reached SEK 2.81. The key question for investors is whether current margins can justify the growth...